Biomarin Pharmaceutical Gross Profit (TTM) Trends

Biomarin Pharmaceutical Inc (BMRN)

70.58 +0.34 (+0.48%) USD | NASDAQ | Sep 27, 16:00

70.59 +0.01 (+0.01%) After-Hours: 20:00

Gross Profit (TTM) Chart

Historical Gross Profit (TTM) Data

View and export this data back to 2005. Upgrade now.

Date	Value
June 30, 2024	2.073B
March 31, 2024	1.956B
December 31, 2023	1.893B
September 30, 2023	1.792B
June 30, 2023	1.725B
March 31, 2023	1.671B
December 31, 2022	1.612B
September 30, 2022	1.532B
June 30, 2022	1.448B
March 31, 2022	1.412B
December 31, 2021	1.376B
September 30, 2021	1.372B
June 30, 2021	1.354B
March 31, 2021	1.311B
December 31, 2020	1.336B
September 30, 2020	1.369B
June 30, 2020	1.445B
March 31, 2020	1.424B
December 31, 2019	1.345B
September 30, 2019	1.264B
June 30, 2019	1.213B
March 31, 2019	1.196B
December 31, 2018	1.176B
September 30, 2018	1.180B
June 30, 2018	1.142B

Date	Value
March 31, 2018	1.109B
December 31, 2017	1.072B
September 30, 2017	1.025B
June 30, 2017	979.98M
March 31, 2017	967.36M
December 31, 2016	907.23M
September 30, 2016	851.18M
June 30, 2016	796.02M
March 31, 2016	759.58M
December 31, 2015	737.89M
September 30, 2015	749.74M
June 30, 2015	722.37M
March 31, 2015	670.88M
December 31, 2014	627.69M
September 30, 2014	565.54M
June 30, 2014	527.74M
March 31, 2014	481.40M
December 31, 2013	460.09M
September 30, 2013	435.90M
June 30, 2013	430.58M
March 31, 2013	416.78M
December 31, 2012	408.89M
September 30, 2012	389.81M
June 30, 2012	377.30M
March 31, 2012	368.22M

Gross Profit Definition

Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.

Read full definition.

Gross Profit (TTM) Range, Past 5 Years

1.264B

Minimum

Sep 2019

2.073B

Maximum

Jun 2024

1.536B

Average

1.434B

Median

Gross Profit (TTM) Benchmarks